Efficacité des bêtabloquants dans les hémangiomes capillaires infantiles : signification physiopathologique et conséquences thérapeutiques
Authors:
- C. Léauté-LabrèzeCLC. Léauté-Labrèze
- A. TaïebATA. Taïeb
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 135 (12) , 860-862
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Placental Anomalies in Children with Infantile HemangiomaPediatric Dermatology, 2007
- Prospective Study of Infantile Hemangiomas: Demographic, Prenatal, and Perinatal CharacteristicsThe Journal of Pediatrics, 2007
- Lack of toxicity from pediatric beta-blocker exposuresHuman & Experimental Toxicology, 2006
- Infantile Hemangiomas: Current Knowledge, Future Directions. Proceedings of a Research Workshop on Infantile HemangiomasPediatric Dermatology, 2005
- Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heartJournal of Biomedical Science, 2005
- Traitement par vincristine des hémangiomes graves du nourrissonArchives de Pédiatrie, 2004
- Hypertension in NeonatesJournal of Perinatal & Neonatal Nursing, 2003
- Oral Corticosteroid Use Is Effective for Cutaneous HemangiomasArchives of Dermatology, 2001
- cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activationJournal of Cellular Biochemistry, 1997